Your search for Program: msp
returned 47 results.

Displaying results 1 through 47.

New Search

Lou Ann Brown, Ph.D. Programs: NHS, Full Member MSP, Full Member Impact of alcoholism (adult and fetal) on pulmonary oxidant injury.

Jing Chen, Ph.D. Programs: MSP, Full Member BCDB, Full Member The pathogenic mechanism of human hematopoietic malignancies and solid tumors.

Michael E. Davis, Ph.D. Programs: MSP, Full Member The delivery of small molecule inhibitors and antioxidants for cardiac regeneration and stem cell therapy.

Raymond Dingledine, Ph.D. Programs: MSP, Full Member NS, Full Member Genetic control of glutamate receptor function.

Paul W. Doetsch, Ph.D. Programs: BCDB, Full Member GMB, Full Member MSP, Full Member Molecular biology of DNA damage and repair.

Henry F. Edelhauser, Ph.D. Programs: MSP, Associate Member NHS, Associate Member Pathogenesis of corneal edema and drug delivery for posterior segment eye disease.

Yue Feng, Ph.D. Programs: MSP, Full Member BCDB, Full Member Posttranscriptional regulation by RNA-binding proteins and microRNA in normal brain function and CNS diseases.

Haian Fu, Ph.D. Programs: BCDB, Full Member MSP, Full Member Signal transduction in normal and cancer cells and drug discovery.

Frank J. Gordon, Ph.D. Programs: MSP, Associate Member NS, Associate Member CNS regulation of the immune and cardiovascular systems.

Kathy Griendling Taylor, Ph.D. Programs: MSP, Full Member Reactive oxygen species in smooth muscle growth; oxidative stress in vascular disease.

Randy A. Hall, Ph.D. Programs: MSP, Full Member NS, Full Member Mechanisms of signal transduction by neurotransmitter and hormone receptors.

David G. Harrison, M.D. Programs: MSP, Full Member Endothelial/vascular smooth muscle interactions as they pertain to regulation of vasomotor tone.

C. Michael M. Hart, M.D. Programs: MSP, Full Member Utilizes animal models to clarify how reactive oxygen and nitrogen species participate in the pathophysiology of systemic and pulmonary vascular disease.

H. Criss Hartzell, Ph.D. Programs: NS, Full Member MSP, Full Member Ion channel regulation and signal transduction.

John R. Hepler, Ph.D. Programs: MSP, Full Member BCDB, Full Member Cellular roles and regulation of novel signaling proteins/pathways used by neurotransmitters.

Leonard Howell, Ph.D. Programs: MSP, Full Member NS, Full Member Behavioral neuropharmacology of CNS stimulants in nonhuman primates.

P. Michael Iuvone, Ph.D. Programs: MSP, Full Member NS, Full Member Circadian rhythms, signal transduction and neuromodulators in the retina.

Hanjoong Jo, Ph.D. Programs: MSP, Full Member Role of blood flow and microgravity on vascular endothelial cell biology and pathophysiology.

Dean P. Jones, Ph.D. Programs: NHS, Full Member MSP, Full Member Diet and cancer; antioxidants and aging.

Clinton D. Kilts, Ph.D. Programs: MSP, Full Member NS, Full Member The application of brain imaging technology to the study of normal and abnormal human behavior.

Michael J. Kuhar, Ph.D. Programs: NS, Full Member MSP, Full Member Neuropharmacology of neuropsychiatric disorders.

Lian Li, Ph.D. Programs: BCDB, Full Member MSP, Full Member Vesicular trafficking in neurotransmission, signal transduction, and neurodegenerative diseases.

Dennis C. Liotta, Ph.D. Programs: MSP, Full Member Sphingolipid-based biomodulators; novel antiviral agents; modeling of chemical and biological systems.

Zixu Mao, M.D./Ph.D. Programs: NS, Full Member MSP, Full Member Molecular and cellular signaling mechanisms of nuclear factor-dependent process in neuronal survival, growth, and degeneration.

Nael McCarty, Ph.D. Programs: MSP, Full Member Structure and function of the ATP-binding cassette (ABC) transporters; pathophysiology in cystic fibrosis.

Gary W. Miller, Ph.D. Programs: MSP, Full Member NS, Full Member Environmental and genetic factors involved in neurological disease.

Edward T. Morgan, Ph.D. Programs: MSP, Full Member Regulation of cytochrome P-450 and other drug metabolizing enzymes in disease states; molecular mechanisms of regulation of gene expression by nitric oxide.

E. Christopher Muly, M.D./Ph.D. Programs: NS, Associate Member MSP, Associate Member Structural basis for cortical function; circuitry of the prefrontal cortex.

T. J. Murphy, Ph.D. Programs: MSP, Full Member Signal transduction and the regulation of gene expression.

Rita Nahta, Ph.D. Programs: MSP, Full Member Mechanism of action of experimental breast cancer therapeutics; growth factor signaling and resistance to targeted therapies in breast cancer.

Charles B. Nemeroff, M.D./Ph.D. Programs: MSP, Full Member NS, Full Member Effects of psychopharmacological agents on brain neuropeptide systems.

Eric Ortlund, Ph.D. Programs: BCDB, Full Member MSP, Full Member Structural biology, molecular biology, biophysics and biochemistry of proteins and protein-nucleic acid complexes.

Michael J. Owens, Ph.D. Programs: NS, Full Member MSP, Full Member Interactions between neuropeptides and clinically efficacious psychotropic drugs; neuropsychopharmacology.

David C. Pallas, Ph.D. Programs: BCDB, Full Member MSP, Full Member Polyomavirus tumor antigen-associated proteins; regulation of cell-cycle control.

Grace K. Pavlath, Ph.D. Programs: BCDB, Full Member MSP, Full Member Adult stem cells, skeletal muscle growth and repair, signal transduction.

Hyunsuk Shim, Ph.D. Programs: MSP, Full Member Molecular imaging, breast cancer metastasis, hypoxia, angiogenesis, tumor-targeted delivery.

Shanthi Sitaraman, M.D./Ph.D. Programs: BCDB, Full Member MSP, Full Member Pathogenesis of Inflammatory Bowel Disease; mechanisms of diarrhea in IBD.

Yoland Smith, Ph.D. Programs: NS, Full Member MSP, Full Member The microcircuitry of the basal ganglia: from synaptic connections to therapeutic strategies in Parkinson's disease.

H. Trent T. Spencer, Ph.D. Programs: MSP, Full Member Drug resistance gene therapy strategies for treatment of childhood cancers and inherited diseases.

Shi-Yong Sun, Ph.D. Programs: MSP, Full Member Regulation of death receptors and their implication in drug-induced apoptosis and cancer therapy; understanding the relationship between mTOR and Akt and its impact on mTOR-targeted cancer therapy.

Roy L. Sutliff, Ph.D. Programs: MSP, Full Member Assessment of cardiovascular pathophysiology in gene-altered mouse models.

W. Robert R. Taylor, M.D./Ph.D. Programs: MSP, Full Member Vascular inflammatory response; macrophage recruitment; hypertensive vascular disease; atherosclerosis.

Stephen F. Traynelis, Ph.D. Programs: MSP, Full Member NS, Full Member Control of glutamate receptor activation in stroke, epilepsy, and normal brain function.

David Weinshenker, Ph.D. Programs: NS, Full Member MSP, Full Member Norepinephrine signaling in genetically-engineered mice.

Thomas Wichmann, M.D. Programs: NS, Full Member MSP, Full Member Primate research on the physiology of the basal ganglia; pathophysiology of movement disorders, such as Parkinson¿s disease.

Lily Yang, M.D./Ph.D. Programs: MSP, Full Member BCDB, Full Member Development of novel approaches for detection and treatment of human cancer.

Keqiang Ye, Ph.D. Programs: MSP, Full Member BCDB, Full Member Functional study of GTPase PIKE (PI 3-kinase enhancer) in the nervous system.

New Search